Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: GELSANA THERAPEUTICS INC
Awarding agency: Department of Defense / Department of the Air Force
Funding agency: Department of Defense / Department of the Air Force
Period of performance: 2023-05-01 to 2023-08-03
Current total value of award: $74950
Description: END-USER EXPLORATION OF NOVEL ZWITTERIONIC HYDROGELS FOR IMPROVED BURN, BLAST, AND CHRONIC WOUND HEALING